Letter in response to the article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome.International journal of molecular sciences · 2023
   Review
2. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review.Trends in food science & technology · 2022
   Review
3. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.Journal of molecular medicine (Berlin, Germany) · 2021
   Review
4. The Human Respiratory System and its Microbiome at a Glimpse.Biology · 2020
   Review
5. Special features of SARS-CoV-2 in daily practice.World journal of clinical cases · 2020
   Review
6. What we have learned for the future about COVID-19 and healthcare management of it?Acta bio-medica : Atenei Parmensis · 2020
   Review
7. Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective.Diabetes & metabolic syndrome
   Review

Corrections and comments

• Commented on by
  Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.).
• Comment on
  Enhancing immunity in viral infections, with special emphasis on COVID-19: A review.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as